Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 68788-7992

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68788-7992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion HCl Extended-release Tablets Usp Xl 300mg (Bupropion 300mg 30 Tab Container Label)

This is a description for Bupropion HCI Extended-Release Tablets USP (XL), a generic form of Wellbutrin. These tablets contain Bupropion Hydrochloride, with 300mg per pill. They are manufactured by Accord Healthcare, Inc. in Durham, NC. The instructions recommend taking the tablet(s) a certain number of times a day. There is a caution that states that this drug should only be used by the patient, as it is prohibited to transfer it to another person. There are additional details such as PK size, Expiration date, Lot number, Batch number, Prod number, and Insurance NDC, but the readability of these numbers is not clear.*

FDA Label Image

Wellbutrin Chemical Structure (Bupropion Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.